Capricor Therapeutics is a San Diego biotechnology company developing a cell therapy for Duchenne muscular dystrophy. It last closed at $7.59 on Nov 20, up 0.80% on the day. The next earnings report for CAPR is expected around Thu, Mar 11, 2027, after the close. For the quarter ended Sep 2026, CAPR reported EPS of -$0.73. Over its last 8 reports the stock moved an average of 16.7% the session after earnings. Over the last 12 months CAPR insiders bought $0 of stock on the open market and sold $8.4M, according to SEC Form 4 filings.
AI Auto Pilots
Is CAPR in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold CAPR.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on CAPRStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
CAPR · as of the Nov 20 close · updated each morning
Moving sideways
The stock is 7% below its 20 day and 6% below its 50 day average. It is 159% below its 200 day average, so the longer trend is down. Momentum is fading (RSI 46). The nearest support is the swing low (Oct 5) at $7.37, and the nearest resistance the Pivot at $7.77.
Short trendNeutral
Long trendBearish
MomentumFading
StretchNormal
VolatilityHigh, 13.8%/day
Key levels
$40.3752 week high+431.9%
$19.65200 day average+158.9%
$9.84100 day average+29.6%
$8.29Swing high (Aug 18)+9.2%
$8.16Pivot R1+7.5%
$8.1320 day average+7.1%
$8.0250 day average+5.7%
$7.77Pivot+2.4%
$7.59Last close
$7.37Swing low (Oct 5)−2.9%
$7.20Pivot S1−5.1%
$2.9652 week low−61.0%
Indicators
RSI (14)
46.13
Middle of its range
Neutral
MACD
0.17
Below its signal line
Bearish
Stochastic
22.3
Middle of its range
Neutral
ADX (14)
27.0
Trending up
Williams %R
-89.2
Oversold below −80, overbought above −20
Oversold
CCI (20)
-21.1
Oversold below −100, overbought above 100
Neutral
Rate of change
−15.7%
Change over 10 sessions
Bearish
ATR (14)
$1.05
Typical daily range, 13.8% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Pullback inside a longer uptrend
Short trendBearish
Long trendBullish
MomentumNeutral
StretchNormal
VolatilityHigh, 37.3%/day
Key levels
$40.3752 week high+431.9%
$19.65200 day average+158.9%
$9.84100 day average+29.6%
$8.29Swing high (Aug 18)+9.2%
$8.16Pivot R1+7.5%
$8.1320 day average+7.1%
$8.0250 day average+5.7%
$7.77Pivot+2.4%
$7.59Last close
$7.37Swing low (Oct 5)−2.9%
$7.20Pivot S1−5.1%
$2.9652 week low−61.0%
Indicators
RSI (14)
38.51
Weak, oversold below 30
Neutral
MACD
-3.55
Above its signal line
Bullish
Stochastic
61.5
Middle of its range
Neutral
ADX (14)
22.5
Weak trend
Williams %R
-65.5
Oversold below −80, overbought above −20
Neutral
CCI (20)
-28.8
Oversold below −100, overbought above 100
Neutral
Rate of change
−9.3%
Change over 10 sessions
Bearish
ATR (14)
$2.83
Typical daily range, 37.3% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for CAPR
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how CAPR did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow CAPR usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for CAPRHow many large options trades hit CAPR, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in CAPR in the last 90 days.
From SEC Form 4 filings by CAPR's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether CAPR is in one of them and how their past CAPR trades turned out.
From official House and Senate disclosure reports, filed up to 45 days after the trade and shown in dollar ranges. Not investment advice. Use limited by 5 U.S.C. 13107. About this data
About Capricor Therapeutics
Capricor Therapeutics is a biotechnology company based in San Diego, California. It is developing Deramiocel, a cell therapy for Duchenne muscular dystrophy, a rare genetic disease that causes progressive muscle loss and weakness. The company is also studying a platform built on exosomes, which are small vesicles released by cells, for other possible diseases. It has no approved products yet, and its target patients are people living with this condition.